Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous versus periodic intravenous iron in maintenance hemodialysis
2012-003914-15Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in anemia of end-stage renal disease, iron deficiency anemia (IDA) and end-stage kidney disease (ESKD) comparing Continuous Ferrinject with Periodic Venofer (2 arms). Primary endpoint: Hemoglobin. Started May 2014; status: completed.
02
Drugs
ferric carboxymaltoseiron sucrose
03
Conditions
anemia of end-stage renal diseaseiron deficiency anemia (IDA)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2012-003914-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003914-15.